Nano-Biotechnology
Interaction of copper oxide nanoparticles with bacterial nucleic acids: a review

Mehran Alavi; Michael R. Hamblin

Articles in Press, Accepted Manuscript, Available Online from 10 November 2022

https://doi.org/10.55705/cmbr.2022.364001.1069

Abstract
  Despite the wide use of conventional antibiotics to treat bacterial infections, bacteria have now become resistant to many antibiotics and other antibacterial agents. This resistance is heritable and allows the spread of intractable bacterial infections, which is one of the biggest health challenges ...  Read More

Nano-Biotechnology
Antibacterial and antioxidant activity of catechin, gallic acid, and epigallocatechin-3-gallate: focus on nanoformulations

Mehran Alavi; Michael R. Hamblin; Ermia Aghaie; Seyed Ali Reza Mousavi; Mohammad Hajimolaali

Articles in Press, Accepted Manuscript, Available Online from 10 November 2022

https://doi.org/10.55705/cmbr.2022.353962.1052

Abstract
  There are up to one million secondary metabolites found in plant species, some of which may have desirable therapeutic activities. Among these secondary metabolites, catechin, gallic acid, and epigallocatechin-3-gallate are natural phenolic compounds with promising antioxidant and antibacterial activity. ...  Read More

Nano-Biotechnology
Antibacterial silver nanoparticles: effects on bacterial nucleic acids

Mehran Alavi; Michael R. Hamblin

Volume 3, Issue 1 , March 2023, , Pages 35-40

https://doi.org/10.55705/cmbr.2022.361677.1065

Abstract
  Various microorganisms are located on the human skin, mucous membrane and inside the human body. Many of these microorganisms are beneficial and few are even essential, however, some pathogens are known to cause infection and have the ability to attack and damage the host tissue. Treatment of infectious ...  Read More

Antibacterial silver nanoparticles: effects on bacterial nucleic acids


Nano-Biotechnology
Surface modification of SiO2 nanoparticles for bacterial decontaminations of blood products

Mehran Alavi; Michael R. Hamblin; M. R. Mozafari; Irwin Rose Alencar de Menezes; Henrique Douglas Melo Coutinho

Volume 2, Issue 2 , June 2022, , Pages 87-97

https://doi.org/10.55705/cmbr.2022.338888.1039

Abstract
  Bacterial infections can be caused by contamination of labile blood products with specific bacteria, such as Staphylococcus aureus and Staphylococcus epidermidis. Hospital equipment, bio-protective equipment, delivery systems, and medical devices can be easily contaminated by microorganisms. Multidrug-resistant ...  Read More

Surface modification of SiO2 nanoparticles for bacterial decontaminations of blood products


Nano-Biotechnology
The efficiency of metal, metal oxide, and metalloid nanoparticles against cancer cells and bacterial pathogens: different mechanisms of action

Mehran Alavi; Mahendra Rai; Fleming Martinez; Danial Kahrizi; Haroon Khan; Irwin Rose Alencar de Menezes; Henrique Douglas Melo Coutinho; José Galberto Martins Costa

Volume 2, Issue 1 , March 2022, , Pages 10-21

https://doi.org/10.55705/cmbr.2022.147090.1023

Abstract
  The applications of nanoparticles in various practical fields, owing to their unique properties compared with bulk materials, have been occupying the minds of scientists for several decades. In this regard, a combination of pharmacology and nanotechnology has contributed to producing newer effective ...  Read More

The efficiency of metal, metal oxide, and metalloid nanoparticles against cancer cells and bacterial pathogens: different mechanisms of action


Nano-Biotechnology
Antisense RNA, the modified CRISPR-Cas9, and metal/metal oxide nanoparticles to inactivate pathogenic bacteria

Mehran Alavi; Mahendra Rai

Volume 1, Issue 2 , August 2021, , Pages 52-59

https://doi.org/10.55705/cmbr.2021.142436.1014

Abstract
  Finding efficient therapeutic strategies to fight antibiotic-resistant bacteria is a complicated affair specifically in the therapy of chronic bacterial infections related to hospital-acquired infections. Recently, three major antibacterial systems based on antisense RNA, CRISPR-Cas9, and metal/metal ...  Read More

Antisense RNA, the modified CRISPR-Cas9, and metal/metal oxide nanoparticles to inactivate pathogenic bacteria